Cargando…
Local immune response depends on p16(INK4a) status of primary tumor in vulvar squamous cell carcinoma
BACKGROUND: The p16(Ink4a) is not a surrogate marker for high-risk human papilloma virus (HPV) genotypes but indicates better prognosis in vulvar squamous cell carcinoma patients. Our recent study confirmed substantial mismatch between p16(Ink4a) and high-risk HPV-status as well as revealed that p16...
Autores principales: | Sznurkowski, Jacek J., Żawrocki, Anton, Biernat, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542260/ https://www.ncbi.nlm.nih.gov/pubmed/28515351 http://dx.doi.org/10.18632/oncotarget.17581 |
Ejemplares similares
-
The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer
por: Sznurkowski, Jacek J., et al.
Publicado: (2016) -
Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma
por: Sznurkowski, Jacek Jan, et al.
Publicado: (2013) -
PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
por: Sznurkowski, Jacek J., et al.
Publicado: (2017) -
Impact of Activation of EGFL7 within Microenvironment of High Grade Ovarian Serous Carcinoma on Infiltration of CD4+ and CD8+ Lymphocytes
por: Sznurkowski, Jacek J., et al.
Publicado: (2022) -
Overexpression of p16(INK4a) Serves as Prognostic Marker in Squamous Cell Vulvar Cancer Patients Treated With Radiotherapy Irrespective of HPV-Status
por: Arians, Nathalie, et al.
Publicado: (2019)